Towards Novel Nonparametric Statistical Methods and Bioinformatics Tools for Clinical and Translational Sciences

As the field of functional genetics and genomics is beginning to mature, we become confronted with new challenges. The constant drop in price for sequencing and gene expression profiling as well as the increasing number of genetic and genomic variables that can be measured makes it feasible to address more complex questions. The success with rare diseases caused by single loci or genes has provided us with a proof-of-concept that new therapies can be developed based on functional genomics and genetics. Common diseases, however, typically involve genetic epistasis, genomic pathways, and proteomic pattern. Moreover, to better understand the underlying biologi-cal systems, we often need to integrate information from several of these sources. Thus, as the field of clinical research moves toward complex diseases, the demand for modern data base systems and advanced statistical methods increases. The traditional statistical methods implemented in most of the bioinformatics tools currently used in the novel field of genetics and functional genomics are based on the linear model and, thus, have shortcomings when applied to nonlinear biological systems. The previous work on partially ordered data (Wittkowski 1988; 1992), when combined with theoretical results (Hoeffding 1948) and computational strategies (Deuchler 1914) has opened a new field of nonparametric statistics. With grid technology, new tools are now feasible when screening for interactions between genetics (Wittkowski, Liu 2002) and functional genomics (Wittkowski, Lee 2004). Having more complex study designs and more specific methods available increases the demand for decision support when selecting appropriate bioinformatics tools. With the advent of rapid prototyping systems for Web based database application, we have recently begun to complement previous work on knowledge based systems with graphical Web-based tools for acquisition of DESIGN and MODEL knowledge.Biostatistics Bioinformatics NIH NCRR ROADMAP

New Statistical Paradigms Leading to Web-Based Tools for Clinical/Translational Science

As the field of functional genetics and genomics is beginning to mature, we become confronted with new challenges. The constant drop in price for sequencing and gene expression profiling as well as the increasing number of genetic and genomic variables that can be measured makes it feasible to address more complex questions. The success with rare diseases caused by single loci or genes has provided us with a proof-of-concept that new therapies can be developed based on functional genomics and genetics. Common diseases, however, typically involve genetic epistasis, genomic pathways, and proteomic pattern. Moreover, to better understand the underlying biologi-cal systems, we often need to integrate information from several of these sources. Thus, as the field of clinical research moves toward complex diseases, the demand for modern data base systems and advanced statistical methods increases. The traditional statistical methods implemented in most of the bioinformatics tools currently used in the novel field of genetics and functional genomics are based on the linear model and, thus, have shortcomings when applied to nonlinear biological systems. The previous work on partially ordered data (Wittkowski 1988; 1992), when combined with theoretical results (Hoeffding 1948) and computational strategies (Deuchler 1914) has opened a new field of nonparametric statistics. With grid technology, new tools are now feasible when screening for interactions between genetics (Wittkowski, Liu 2002) and functional genomics (Wittkowski, Lee 2004). Having more complex study designs and more specific methods available increases the demand for decision support when selecting appropriate bioinformatics tools. With the advent of rapid prototyping systems for Web based database application, we have recently begun to complement previous work on knowledge based systems with graphical Web-based tools for acquisition of DESIGN and MODEL knowledge

From access and integration to mining of secure genomic data sets across the grid

The UK Department of Trade and Industry (DTI) funded BRIDGES project (Biomedical Research Informatics Delivered by Grid Enabled Services) has developed a Grid infrastructure to support cardiovascular research. This includes the provision of a compute Grid and a data Grid infrastructure with security at its heart. In this paper we focus on the BRIDGES data Grid. A primary aim of the BRIDGES data Grid is to help control the complexity in access to and integration of a myriad of genomic data sets through simple Grid based tools. We outline these tools, how they are delivered to the end user scientists. We also describe how these tools are to be extended in the BBSRC funded Grid Enabled Microarray Expression Profile Search (GEMEPS) to support a richer vocabulary of search capabilities to support mining of microarray data sets. As with BRIDGES, fine grain Grid security underpins GEMEPS

Towards data grids for microarray expression profiles

The UK DTI funded Biomedical Research Informatics Delivered by Grid Enabled Services (BRIDGES) project developed a Grid infrastructure through which research into the genetic causes of hypertension could be supported by scientists within the large Wellcome Trust funded Cardiovascular Functional Genomics project. The BRIDGES project had a focus on developing a compute Grid and a data Grid infrastructure with security at its heart. Building on the work within BRIDGES, the BBSRC funded Grid enabled Microarray Expression Profile Search (GEMEPS) project plans to provide an enhanced data Grid infrastructure to support richer queries needed for the discovery and analysis of microarray data sets, also based upon a fine-grained security infrastructure. This paper outlines the experiences gained within BRIDGES and outlines the status of the GEMEPS project, the open challenges that remain and plans for the future

Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?

The organization and mining of malaria genomic and post-genomic data is highly motivated by the necessity to predict and characterize new biological targets and new drugs. Biological targets are sought in a biological space designed from the genomic data from Plasmodium falciparum, but using also the millions of genomic data from other species. Drug candidates are sought in a chemical space containing the millions of small molecules stored in public and private chemolibraries. Data management should therefore be as reliable and versatile as possible. In this context, we examined five aspects of the organization and mining of malaria genomic and post-genomic data: 1) the comparison of protein sequences including compositionally atypical malaria sequences, 2) the high throughput reconstruction of molecular phylogenies, 3) the representation of biological processes particularly metabolic pathways, 4) the versatile methods to integrate genomic data, biological representations and functional profiling obtained from X-omic experiments after drug treatments and 5) the determination and prediction of protein structures and their molecular docking with drug candidate structures. Progresses toward a grid-enabled chemogenomic knowledge space are discussed.Comment: 43 pages, 4 figures, to appear in Malaria Journa

Systems analysis of host-parasite interactions.

Parasitic diseases caused by protozoan pathogens lead to hundreds of thousands of deaths per year in addition to substantial suffering and socioeconomic decline for millions of people worldwide. The lack of effective vaccines coupled with the widespread emergence of drug-resistant parasites necessitates that the research community take an active role in understanding host-parasite infection biology in order to develop improved therapeutics. Recent advances in next-generation sequencing and the rapid development of publicly accessible genomic databases for many human pathogens have facilitated the application of systems biology to the study of host-parasite interactions. Over the past decade, these technologies have led to the discovery of many important biological processes governing parasitic disease. The integration and interpretation of high-throughput -omic data will undoubtedly generate extraordinary insight into host-parasite interaction networks essential to navigate the intricacies of these complex systems. As systems analysis continues to build the foundation for our understanding of host-parasite biology, this will provide the framework necessary to drive drug discovery research forward and accelerate the development of new antiparasitic therapies